PATHO-GENE^® AP-NBT/BCIP HPV in situ screening assay

The PATHO-GENE^® Human papillomavirus (HPV) in situ screening assay for tissue sections provides reagents and materials for (a) preparation and pretreatment and (b) hybridization/ detection and typing of HPV DNA (using alkaline phosphatase-NBT/BCIP for signal generation) in 20 tissue biopsy specimens. This product is for research use only and is not to be used for diagnostic procedures.

The PATHO-GENE^® Human papillomavirus (HPV) in situ screening assay for tissue sections employs a mixture of HPV-specific probes that have been specially formulated to detect most HPV types that have been associated with anogenital papillomas. Among the HPV types detected with this assay system are those commonly associated with benign lesions presenting as condylomas and mild dysplasia, as well as types commonly associated with cervical intraepithelial neoplasia (CIN) and carcinoma in situ (CIS). The PATHO-GENE^® Human papillomavirus (HPV) in situ screening assay for tissue sections can be used to detect HPV DNA in tissue sections under conditions that preserve cellular morphology.